Delivery Order SPE2DB20D2014-SPE2DB25FB16W

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,422.56 firm-fixed-price delivery order is for the supply of 10,000 units of PROCRIT 10,000 units/mL vials. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,165.86 firm fixed price delivery order is for the procurement of 40,000 units of PROCRIT 40,000 units/mL vial. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,488.38 firm fixed price delivery order is for the supply of 20,000 units of PROCRIT 20,000 units/mL vials. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 40,000 units of PROCRIT 40,000 units/mL vials. The $2,509.46 firm fixed-price delivery order has an ultimate completion date of August 15, 2022. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,217.72 firm fixed-price delivery order contract is for the provision of 4,000 units/mL of the medication PROCRIT. The award has an ultimate completion date of December 5, 2024 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,837.39, is for the procurement of 10,000 units of PROCRIT 10,000 units/mL vials. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,617.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 40,000 units/ml of the drug PROCRIT, a medication used to treat anemia. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.74 firm fixed-price delivery order is for the supply of 20,000 units/mL of the medication PROCRIT. The contract has an ultimate completion date of January 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,841.54 firm fixed-price delivery order is for the supply of 10,000 units/ml of the medication PROCRIT. This award is not associated with any set-aside program. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive...
This federal contract award, with ID SPE2DX15D1022|SPE2DX25FUZYA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.08 fixed-price delivery order is for the supply of 10,000 units of the medication PROCRIT in 2 ml vials. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen holds a larger $999,999,999...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB16W
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,301.80 firm fixed-price delivery order is for the procurement of 3,000 units of PROCRIT 3,000 units/mL vials. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's procurement of essential pharmaceutical commodities.

Generated 6/1/25, 2:58 AM